Sanofi-Synthelabo launches Cronosphere, innovative anti-epileptic drug

Published: 2004-06-09 06:57:00
Updated: 2004-06-09 06:57:00
Sanofi-Synthelabo said it has launched Cronosphere, a novel dosage form of Depakine (sodium valproate) for the treatment of epilepsy.

Cronosphere is a sustained release dosage form using a prilling method.

Spherical microbeads of uniform size are widely used in the pharmaceutical industry,...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.